Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens

Effectiveness of varenicline for smoking cessation at 2 urban academic health centers

(2012) Ranjit K. Dhelaria et al.   European Journal of Internal Medicine

Striatal Dopamine Release Is Triggered by Synchronized Activity in Cholinergic Interneurons

(2012) Sarah Threlfell et al.   NEURON

Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include α5 or α6 subunits and that mediate synaptosomal neurotransmitter release

(2012) Sharon R. Grady et al.   NEUROPHARMACOLOGY

Galantamine, an Acetylcholinesterase Inhibitor and Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors, Attenuates Nicotine Taking and Seeking in Rats

(2012) Thomas J Hopkins et al.   NEUROPSYCHOPHARMACOLOGY

Preclinical Evidence That Activation of Mesolimbic Alpha 6 Subunit Containing Nicotinic Acetylcholine Receptors Supports Nicotine Addiction Phenotype

(2012) D. H. Brunzell   NICOTINE & TOBACCO RESEARCH

Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades?

(2012) Shu-Hong Zhu et al.   TOBACCO CONTROL

Selective Activation of Cholinergic Interneurons Enhances Accumbal Phasic Dopamine Release: Setting the Tone for Reward Processing

(2012) Roger Cachope et al.   Cell Reports

Reward, Addiction, Withdrawal to Nicotine

(2011) Mariella De Biasi et al.   Annual Review of Neuroscience

Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior

(2011) Luis M. Tuesta et al.   BIOCHEMICAL PHARMACOLOGY

Mechanistic insights into nicotine withdrawal

(2011) Michael Paolini et al.   BIOCHEMICAL PHARMACOLOGY

Nicotine-Mediated Activation of Dopaminergic Neurons in Distinct Regions of the Ventral Tegmental Area

(2011) Rubing Zhao-Shea et al.   NEUROPSYCHOPHARMACOLOGY

Dopamine release in the basal ganglia

(2011) M.E. Rice et al.   NEUROSCIENCE

 6 2* and  4 2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease

(2011) M. Quik et al.   PHARMACOLOGICAL REVIEWS

Distinct contributions of nicotinic acetylcholine receptor subunit  4 and subunit  6 to the reinforcing effects of nicotine

(2011) R. Exley et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nicotinic Acetylcholine Receptors in the Mesolimbic Pathway: Primary Role of Ventral Tegmental Area  6 2* Receptors in Mediating Systemic Nicotine Effects on Dopamine Release, Locomotion, and Reinforcement

(2010) C. Gotti et al.   JOURNAL OF NEUROSCIENCE

 6 2* and  4 2* Nicotinic Receptors Both Regulate Dopamine Signaling with Increased Nigrostriatal Damage: Relevance to Parkinson's Disease

(2010) X. A. Perez et al.   MOLECULAR PHARMACOLOGY

Expression of Functional Human  6 2 3* Acetylcholine Receptors in Xenopus laevis Oocytes Achieved through Subunit Chimeras and Concatamers

(2010) A. Kuryatov et al.   MOLECULAR PHARMACOLOGY

Nicotine addiction and nicotinic receptors: lessons from genetically modified mice

(2010) Jean-Pierre Changeux   NATURE REVIEWS NEUROSCIENCE

Nicotine Addiction

(2010) Neal L. Benowitz   NEW ENGLAND JOURNAL OF MEDICINE

Varenicline

(2010) Gillian M. Keating et al.   PHARMACOECONOMICS

Cholinergic Functioning in Stimulant Addiction

(2009) Mehmet Sofuoglu et al.   CNS DRUGS

Dopamine Signaling Differences in the Nucleus Accumbens and Dorsal Striatum Exploited by Nicotine

(2009) T. Zhang et al.   JOURNAL OF NEUROSCIENCE

The Role of  6-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal

(2009) K. J. Jackson et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Prominent Role of  3/ 6 2* nAChRs in Regulating Evoked Dopamine Release in Primate Putamen: Effect of Long-Term Nicotine Treatment

(2009) X. A. Perez et al.   MOLECULAR PHARMACOLOGY

Controls of Tonic and Phasic Dopamine Transmission in the Dorsal and Ventral Striatum

(2009) L. Zhang et al.   MOLECULAR PHARMACOLOGY

Roles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and addiction

(2009) Roy A. Wise   TRENDS IN NEUROSCIENCES

Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens

(2008) Laurie H. L. Sellings et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

The neuronal nicotinic acetylcholine receptors α4* and α6* differentially modulate dopamine release in mouse striatal slices

(2008) Erin L. Meyer et al.   JOURNAL OF NEUROCHEMISTRY

Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates

(2008) Xiomara A. Perez et al.   JOURNAL OF NEUROCHEMISTRY

Crucial Role of  4 and  6 Nicotinic Acetylcholine Receptor Subunits from Ventral Tegmental Area in Systemic Nicotine Self-Administration

(2008) S. Pons et al.   JOURNAL OF NEUROSCIENCE

Long-Term Nicotine Treatment Differentially Regulates Striatal  6 4 2* and  6(Non 4) 2* nAChR Expression and Function

(2008) X. A. Perez et al.   MOLECULAR PHARMACOLOGY